Integrity Alliance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.79M Buy
8,162
+387
+5% +$395K 0.31% 72
2026
Q1
$7.15M Sell
7,775
-515
-6% -$522K 0.27% 84
2025
Q4
$8.91M Buy
8,290
+4,011
+94% +$3.84M 0.33% 80
2025
Q3
$3.27M Buy
4,279
+484
+13% +$360K 0.15% 122
2025
Q2
$2.96M Sell
3,795
-6,512
-63% -$5.06M 0.16% 118
2025
Q1
$8.51M Buy
10,307
+9,234
+861% +$7.68M 0.34% 70
2024
Q4
$828K Buy
+1,073
New +$888K 0.09% 105

Other funds holding LLY

Integrity Alliance's LLY Position: Q2 2026 in Review

Integrity Alliance increased its Eli Lilly (LLY) stake by 5% in Q2 2026, buying an estimated $395K and bringing the position to 8,162 shares worth $9.79M. The position accounts for 0.31% of the portfolio, ranked #72.

Integrity Alliance first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Integrity Alliance held 8,162 shares of Eli Lilly worth $9.79M as of Q2 2026.
  • Integrity Alliance bought 387 Eli Lilly shares in Q2 2026, an estimated $395K.
  • Eli Lilly made up 0.31% of Integrity Alliance's portfolio in Q2 2026, its #72 holding.
  • Integrity Alliance first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.